Vinay Prasad: Why financial conflict is a special problem in oncology https://t.co/Dfx7k6BOKB …: Why… https://t.co/c14x8PMCWN #MedicBoard https://t.co/Xeh276fIRy
Vinay Prasad: Why financial conflict is a special problem in oncology https://t.co/Dfx7k6BOKB …: Why… https://t.co/w1jPpdvRRt #MedicBoard https://t.co/RUkJ7X0DAJ
RT @AntonioAddis2: Innovatività "speciale" in oncologia merita attenzione per COI "speciale" @lucadf @forwardRPM @fperrone62 https://t.co/K…
RT @AntonioAddis2: Innovatività "speciale" in oncologia merita attenzione per COI "speciale" @lucadf @forwardRPM @fperrone62 https://t.co/K…
We increasingly hear pleas for the use of "life-saving drugs" (really "adding a small increment"): this article sets a good perspective. https://t.co/gAaB0LSBTV
@amcnicho mira a ver si te gusta (a mi mucho) este editorial https://t.co/NWi0lTioL3
RT @fgomollon: @VinayPrasad82 THANKS for this exceptional piece.As an academic with COI (not in oncology)I fully support your views https:/…
Vinay Prasad: Why financial conflict is a special problem in oncology https://t.co/Dfx7k6BOKB …: Why… https://t.co/gaUFbtKPqb #MedicBoard https://t.co/AzlFeu2lZ0
@VinayPrasad82 THANKS for this exceptional piece.As an academic with COI (not in oncology)I fully support your views https://t.co/NWi0lTioL3
Innovatività "speciale" in oncologia merita attenzione per COI "speciale" @lucadf @forwardRPM @fperrone62 https://t.co/K4NSlf9NfH
Conflict of interest in academic oncology: moving beyond the blame game and forging a path forward https://t.co/cLlE6EDqjm @MarikaSboros
Conflict of interest in academic oncology: moving beyond the blame game and forging a path forward https://t.co/cLlE6EDqjm @CANSA
Very hopeful these recommendations are implemented asap - keep us informed https://t.co/hB2IquxCwm
RT @oncology_bg: Excellent editorial! The best part is that the editorial also proposes good solutions. Completely agree. https://t.co/J44…
RT @H3ath3rBlock: Patients need to know CoI and how it influences our oncologists https://t.co/1DyVlSoCsK
Faire lire à Agnès Buzyn un article de @VinayPrasad82 sur les conflits d'intérêts en oncologie. https://t.co/QenbfHpNCW
Patients need to know CoI and how it influences our oncologists https://t.co/1DyVlSoCsK
RT @VincentRK: cc: @jocalynclark We call on @TheLancet @TheLancetOncol @NEJM @JAMA_current @ASH_hematology @ASCO to be stricter with review…
RT @VincentRK: Why are conflicts of interest of particular importance & concern in Oncology? https://t.co/uYBAUDqhu2 @MayoClinic @MayoProce…
cc: @jocalynclark We call on @TheLancet @TheLancetOncol @NEJM @JAMA_current @ASH_hematology @ASCO to be stricter with reviews & editorials https://t.co/4Ctmjhnp5W
Why are conflicts of interest of particular importance & concern in Oncology? https://t.co/uYBAUDqhu2 @MayoClinic @MayoProceedings #BCJ #COI https://t.co/FdlVv6cu40
RT @Perbess: Conflictos de intereses en #Oncología Influyen en tratamientos coste toxicidad https://t.co/C8Rtj4Oz7X Por @VinayPrasad82 y @…
Conflictos de intereses en #Oncología Influyen en tratamientos coste toxicidad https://t.co/C8Rtj4Oz7X Por @VinayPrasad82 y @VincentRK https://t.co/hjH0nmbry8
RT @Vilavaite: Financial Conflicts in #Oncology can influence treatment, cost and toxicity #COI https://t.co/v1X9bREwDO Via @VinayPrasad82…
Disclosure of COI does not eliminate the conflict. Also provides no guidance for reader. https://t.co/gQ8KCcUtY0
RT @Vilavaite: Financial Conflicts in #Oncology can influence treatment, cost and toxicity #COI https://t.co/v1X9bREwDO Via @VinayPrasad82…
RT @Vilavaite: Financial Conflicts in #Oncology can influence treatment, cost and toxicity #COI https://t.co/v1X9bREwDO Via @VinayPrasad82…
Financial Conflicts in #Oncology can influence treatment, cost and toxicity #COI https://t.co/v1X9bREwDO Via @VinayPrasad82 @VincentRK https://t.co/BarGy9je6O
Propositions de Vinay Prasad pour lutter contre l'influence des conflits d'intérêts en oncologie https://t.co/fbjhDk69kk
RT @VincentRK: And folks please read the whole paper. We are not staying don't have COI or that it's bad. https://t.co/42aDq9taYq
RT @VincentRK: And folks please read the whole paper. We are not staying don't have COI or that it's bad. https://t.co/42aDq9taYq
RT @VincentRK: Conflict of Interest in oncology-Big problem @VinayPrasad82 @mtmdphd @DrMJoyner @BERector @ASlavitt BCJ #openaccess https:/…
RT @oncology_bg: Excellent editorial! The best part is that the editorial also proposes good solutions. Completely agree. https://t.co/J44…
RT @VincentRK: Conflict of Interest in oncology-Big problem @VinayPrasad82 @mtmdphd @DrMJoyner @BERector @ASlavitt BCJ #openaccess https:/…
Sometimes, the windmills needs tilting at. https://t.co/lncZ7C8myf
RT @VincentRK: And folks please read the whole paper. We are not staying don't have COI or that it's bad. https://t.co/42aDq9taYq
Excellent editorial! The best part is that the editorial also proposes good solutions. Completely agree. https://t.co/J44ANqyWss
Conflict of interest in academic oncology @cherejoblo https://t.co/s7LXhnwwsu
Conflict of interest in academic oncology: moving beyond the blame game and forging a path forward @felly500 Excellent exposè @PECjournal https://t.co/E6tH2eTAiV
RT @lucadf: The top opinion leaders influence in Oncology is disproportionate. Conflict of interests disclosure is not enough. https://t.co…
RT @VinayPrasad82: Financial Conflicts in Oncology; Pervasive and problematic. @VincentRK & I try to find some middle ground https://t.c…
RT @lucadf: The top opinion leaders influence in Oncology is disproportionate. Conflict of interests disclosure is not enough. https://t.co…
RT @lucadf: The top opinion leaders influence in Oncology is disproportionate. Conflict of interests disclosure is not enough. https://t.co…
The top opinion leaders influence in Oncology is disproportionate. Conflict of interests disclosure is not enough. https://t.co/CsHepOa0pM
RT @VincentRK: And folks please read the whole paper. We are not staying don't have COI or that it's bad. https://t.co/42aDq9taYq
RT @VincentRK: And folks please read the whole paper. We are not staying don't have COI or that it's bad. https://t.co/42aDq9taYq
And folks please read the whole paper. We are not staying don't have COI or that it's bad. https://t.co/42aDq9taYq
Conflict Of Interest In Academic Oncology The management of financial conflict of interest (COI) in academic... https://t.co/EldiscP5cP
RT @VincentRK: Editorial On COI #OpenAccess in #BCJ @SpringerNature #NaturePublishingGroup @VinayPrasad82 @fischmd @MayoClinic https://t.co…
"Conflict of interest in academic oncology: moving beyond the blame game and forging a path forward" #SWOGOnc #hpeonc https://t.co/kZ5HmZ5WIo
RT: great piece, but recall that ASCO & ASH receive millions from industry & are exempt as societies from disclosing the amount. Fair? Why? https://t.co/HyVnCJkO1Y
RT @VincentRK: Editorial On COI #OpenAccess in #BCJ @SpringerNature #NaturePublishingGroup @VinayPrasad82 @fischmd @MayoClinic https://t.co…
RT @VincentRK: Editorial On COI #OpenAccess in #BCJ @SpringerNature #NaturePublishingGroup @VinayPrasad82 @fischmd @MayoClinic https://t.co…
RT @VincentRK: Conflict of Interest in oncology-Big problem @VinayPrasad82 @mtmdphd @DrMJoyner @BERector @ASlavitt BCJ #openaccess https:/…
Conflict of Interest in oncology-Big problem @VinayPrasad82 @mtmdphd @DrMJoyner @BERector @ASlavitt BCJ #openaccess https://t.co/uYBAUDqhu2